# EPA和DHA Omega-3成分市场

> EPA和DHA Omega-3成分市场研究报告，按来源（鱼油、藻油、磷虾油、亚麻籽油、奇亚籽油）、按形式（液体、软胶囊、粉末、胶囊、乳剂）、按应用（营养保健品、食品饮料、制药、化妆品、动物饲料）、按最终用途（人类健康、宠物护理、水产养殖、婴儿配方、功能性食品）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.33%
- **2024:** $ 3.82 Billion
- **2025:** $ 4.02 Billion
- **2035:** $ 6.77 Billion
- **Key Players:** DSM Nutritional Products (CH), BASF SE (DE), Cargill, Incorporated (US), Omega Protein Corporation (US), Martek Biosciences Corporation (US), Aker BioMarine (NO), Epax AS (NO), Kewpie Corporation (JP), FMC Corporation (US)

**Report ID:** MRFR/FnB/36337-HCR · **Pages:** 128 · **Author:** Sakshi Gupta · **Last Updated:** September 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/epa-and-dha-omega-3-ingredient-market-38303

---

## Market Summary

## **Global EPA and DHA Omega-3 Ingredient Market Overview**

EPA and DHA Omega-3 Ingredient Market Size was estimated at 3.82 (USD Billion) in 2024. The EPA and DHA Omega-3 Ingredient Industry is expected to grow from 4.03 (USD Billion) in 2025 to 6.42 (USD Billion) by 2034. The EPA and DHA Omega-3 Ingredient Market CAGR (growth rate) is expected to be around 5.3% during the forecast period (2025 - 2034).

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Key EPA and DHA Omega-3 Ingredient Market Trends Highlighted**

The EPA and DHA Omega 3 Ingredients Market deals with many market drivers, which, in a way, create a conducive environment for the demand for omega-3 fatty acids to grow. Notably, the market growth is being fueled by the increasing knowledge related to the consumption of Omega Three for better heart health and better cognitive capabilities. Added to this is the increase in the number of people suffering from chronic illnesses like heart and mental illnesses, together with a growing aged population who are looking for ways to be preventive.

The shift towards more natural and organic products has also been instrumental in driving people to search for omega-3 food sources and supplements.

In relation to the target market, opportunities in the market are many, especially with consumers becoming more health conscious. Nonetheless, the growing popularity of plant and algae-based omega-3 products is opening up new market segments and providing consumers seeking vegan and environment-friendly alternatives. Companies can also consider partnerships in the food industry to enhance varieties of products containing EPA and DHA, which in return can boost their presence in the market. There are also emerging markets in which omega-3 awareness is being created, presenting an opportunity for the brands to penetrate early in the markets.

The trends observed recently show increased levels of omega-3 fortifications in functional foods and functional beverages.

This indicates a trend among consumers towards health but also ease of use. Some new formats like gummies and beverages, are also adding value to the experience of intake. Nutrition personalized on the basis of individual health requirements is getting popular, which allows for custom made omega-3 supplements. Eco-friendly packaging and the production process of goods become one of critical parameters in the purchasing decision, and that forces manufacturers to be more open and responsible. All in all, the scene is changing, and it offers great opportunities for those who are dealing with the omega-3 ingredient sector.

**EPA and DHA Omega-3 Ingredient Market Drivers**

Rising Health Awareness and Demand for Nutritional Supplements

The EPA and DHA Omega-3 Ingredient Market Industry is experiencing significant growth driven by a heightened awareness regarding health issues and the nutritional benefits of omega-3 fatty acids. As consumers become more informed about the importance of maintaining a balanced diet, there is an increasing inclination towards dietary supplements, particularly those containing omega-3s like EPA and DHA. This shift in consumer behavior is largely attributed to concerns over chronic diseases, cardiovascular health, and overall wellness.

Health professionals and nutritionists are advocating the inclusion of omega-3 fatty acids in daily diets, further propelling the demand for products enriched with these nutrients. Additionally, with the growing trend towards preventive healthcare, consumers are proactively seeking supplements that not only address deficiencies but also promote overall health. The trend is particularly noticeable among millennials and health-conscious individuals who are not only focused on physical fitness but are also looking for holistic approaches to health management.

Furthermore, the rise of the wellness movement globally has led to greater acceptance and incorporation of omega-3 supplements into daily routines, thus boosting the growth trajectory of the EPA and DHA Omega-3 Ingredient Market Industry. This market driver is expected to sustain its relevance as awareness levels continue to grow and consumer preferences shift towards natural and efficacious health solutions.

Increasing Adoption of Omega-3 in Functional Foods and Beverages

The incorporation of EPA and DHA omega-3 ingredients into functional foods and beverages is another crucial driver for the EPA and DHA Omega-3 Ingredient Market Industry. As consumers seek healthier options, manufacturers are responding by developing products that offer not just nourishment but also added health benefits. Functional foods fortified with omega-3 fatty acids are increasingly being marketed for their advantages in brain health, heart health, and inflammation reduction.

The growing trend of clean labels and transparency in food labeling has also encouraged producers to include beneficial ingredients like omega-3, resulting in a more informed consumer who actively chooses products that enhance their health.

Regulatory Support and Initiatives Promoting Omega-3 Consumption

Regulatory bodies across various regions are playing a pivotal role in promoting the consumption of omega-3 fatty acids, which is acting as a significant driver in the EPA and DHA Omega-3 Ingredient Market Industry. Various health organizations provide guidelines that emphasize the importance of including omega-3s in daily diets, thus raising awareness and influencing consumer behavior. This endorsement from health authorities encourages the development and marketing of omega-3-enriched products, leading to enhanced availability in markets.

Moreover, with increasing scientific research supporting the health benefits of EPA and DHA, there is a stronger push for regulatory reforms that facilitate the introduction of new omega-3 products, contributing to market growth.

**EPA and DHA Omega-3 Ingredient Market Segment Insights**

**EPA and DHA Omega-3 Ingredient Market Source Insights  **

The EPA and DHA Omega-3 Ingredient Market is witnessing substantial growth, particularly within the Source segment, which comprises various oils known for their omega-3 fatty acids. As of 2023, the overall market was valued at 3.45 USD Billion, and it is expected to reach 5.5 USD Billion by 2032. This segment includes key players like Fish Oil, Algal Oil, Krill Oil, Flaxseed Oil, and Chia Seed Oil, each contributing significantly to the market dynamics.

Fish Oil is currently dominating the market with a valuation of 1.65 USD Billion in 2023, reflecting its widespread acceptance due to its rich EPA and DHA content, which are essential for heart and brain health.

The growth of this segment is driven largely by rising consumer awareness regarding the health benefits of omega-3s, making Fish Oil a majority holding in the Source category. Algal Oil, valued at 0.75 USD Billion in 2023, is gaining traction as a plant-based alternative, appealing particularly to vegetarians and vegans. Its significance lies in its sustainable sourcing and high DHA content, which aligns with the growing eco-conscious consumer trend. Krill Oil, while smaller with a market value of 0.5 USD Billion in 2023, plays a niche role due to its antioxidant properties, particularly astaxanthin, attracting a health-focused demographic.

The Flaxseed Oil segment, valued at 0.35 USD Billion, is significant for its role in plant-based omega-3 sources, although it primarily contains ALA, which the body must convert to EPA and DHA, explaining its smaller market share. Lastly, Chia Seed Oil, at 0.2 USD Billion, holds a minor position, yet it is recognized for its versatile usage in food and nutrition products, adding a layer of market diversity. The insights from the EPA and DHA Omega-3 Ingredient Market data indicate an evolution in consumer preferences, highlighting the importance of sustainable and plant-based sources alongside traditional options like Fish Oil.

The market's continued growth is backed by increasing health consciousness, demand for clean-label products, and a shift toward supplements with proven health benefits. As trends evolve, opportunities for expansion in the Source segment remain promising, especially with innovations in extraction and formulation methods that enhance the bioavailability of omega-3s. The EPA and DHA Omega-3 Ingredient Market industry is expected to benefit from these trends, addressing the challenges of sourcing and sustainability while catering to a wider range of dietary preferences.

With various sources contributing to the overall revenue pool, the market segmentation reflects both consumer demand and market opportunity for the industry as a whole.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**EPA and DHA Omega-3 Ingredient Market Form Insights  **

The EPA and DHA Omega-3 Ingredient Market, with a valuation expected to reach 3.45 USD Billion in 2023, showcases a diverse landscape within the Form segment. This segment comprises various formats, including Liquid, Softgel, Powder, Capsule, and Emulsion, each serving unique consumer preferences and applications. Liquid forms are often favored for their versatility in incorporation into foods and beverages, while Softgels provide a convenient and tasteless option that appeals to health-conscious consumers. Powders see significant demand due to their easy mixability in dietary supplements and functional foods.

Capsules maintain a strong presence as they are seen as a traditional form of supplementation. Emulsions are emerging as significant due to their ability to enhance the bioavailability of omega-3 fatty acids, making them an attractive choice in the functional foods sector. These diverse forms cater to varied demographics, driven by growing health awareness and an increasing preference for omega-3-rich diets. Overall, the EPA and DHA Omega-3 Ingredient Market segmentation reflects an evolving industry poised for growth, supported by an expanding consumer base and rising health trends.

**EPA and DHA Omega-3 Ingredient Market Application Insights  **

The EPA and DHA Omega-3 Ingredient Market is poised for notable growth, particularly in the Application segment, which encompasses a range of industries such as nutraceuticals, food & beverages, pharmaceuticals, cosmetics, and animal feed. In 2023, the market was valued at 3.45 billion USD, reflecting a growing awareness of the health benefits associated with Omega-3 fatty acids. Nutraceuticals play a crucial role, driven by the rising demand for dietary supplements that support heart health and cognitive function. The food & beverages sector also remains significant as consumers increasingly seek functional ingredients that enhance nutritional profiles.

Pharmaceuticals leverage Omega-3s for various therapeutic applications, highlighting their importance in health management. Meanwhile, the cosmetics industry utilizes these ingredients for their moisturizing and anti-inflammatory properties, appealing to a demographic focused on natural skincare solutions. Additionally, the animal feed sector benefits from the inclusion of Omega-3s, promoting health in livestock and aquaculture. The diverse applications of EPA and DHA Omega-3 ingredients underscore their essential roles across multiple industries, driving continuous market growth.

**EPA and DHA Omega-3 Ingredient Market End-Use Insights  **

The EPA and DHA Omega-3 Ingredient Market, valued at 3.45 billion USD in 2023, showcases a diverse array of applications across various end uses, reflecting the increasing awareness of the health benefits associated with omega-3 fatty acids. Human health remains a crucial focus, driven by dietary supplements and functional foods that emphasize wellness and preventive care. The pet care segment is likewise expanding as pet owners prioritize nutritional benefits, showcasing a growing trend of enhanced formulations targeting animal health.

Aquaculture, which plays a significant role, indicates the need for sustainable fish farming practices reliant on high-quality omega-3 sources to boost both fish health and product quality.

Infant formulas, a vital market area, emphasize the critical role that DHA plays in cognitive and visual development, making these products essential for early-life nutrition. Meanwhile, functional foods are gaining traction as consumers seek enriched products that boost health, wellness, and overall quality of life. Overall, these segments reflect the growing demand and potential within the EPA and DHA Omega-3 Ingredient Market, driven by health-conscious consumers and a shift towards natural, beneficial ingredients across various industries.

**EPA and DHA Omega-3 Ingredient Market Regional Insights  **

The EPA and DHA Omega-3 Ingredient Market is projected to experience significant growth across various regional segments. In 2023, North America held a dominant position with a market valuation of 0.93 USD Billion, expected to rise to 1.404 USD Billion by 2032, showcasing its majority holding in the market. Europe follows closely, appreciating from 0.775 USD Billion to 1.248 USD Billion, indicating its significant demand driven by consumer awareness of health benefits. Meanwhile, the APAC region is expected to grow from 0.853 USD Billion to 1.482 USD Billion as increasing health consciousness and rising disposable income boost market consumption.

South America, with a 2023 valuation of 0.543 USD Billion, is also anticipated to grow steadily to 0.780 USD Billion, reflecting increasing dietary supplement adoption. The MEA region, though least valued at 0.349 USD Billion in 2023, could see growth to 0.585 USD Billion, suggesting a gradual interest in omega-3 supplements. The distribution of values across these regions highlights varying levels of awareness, regulatory support, and consumer trends, contributing to the overall EPA and DHA Omega-3 Ingredient Market revenue.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**EPA and DHA Omega-3 Ingredient Market Key Players and Competitive Insights**

The EPA and DHA Omega-3 Ingredient Market has gained significant traction in recent years, fueled by increasing awareness of the health benefits associated with omega-3 fatty acids. The competitive landscape of this market is characterized by a blend of established players and emerging companies that are striving to secure their positions through various strategies. These strategies include technological advancements, product diversification, and collaborative efforts in research and development to cater to the ever-evolving consumer demands.

The push towards healthier dietary choices has prompted companies to innovate and expand their portfolios, aiming to fulfill the requirements of health-conscious consumers and leveraging the potential of omega-3 fatty acids in various applications such as dietary supplements, food and beverages, and pharmaceuticals. The competitive environment is marked by rigorous competition, regulatory challenges, and the need for sustainable sourcing of raw materials, further intricately shaping market dynamics and growth pathways.

Cargill has established a prominent market presence within the EPA and DHA Omega-3 Ingredient Market, leveraging its extensive experience and resources in the food and nutrition sector. Cargill's strengths lie in its superior manufacturing capabilities, comprehensive supply chain integration, and commitment to sustainability, which resonate well with the growing consumer demand for ethically sourced ingredients. The company's robust research and development efforts enable it to innovate and produce high-quality omega-3 products that meet stringent regulatory standards and cater to diverse dietary needs.

Additionally, Cargill's footprint allows it to effectively engage with a wide customer base, fostering strong relationships with clients across various sectors, including food and beverage, dietary supplements, and pet nutrition. This strategic positioning underpins Cargill's ability to maintain a competitive edge in the market and respond adeptly to emerging trends.

Croda International is another key player in the EPA and DHA Omega-3 Ingredient Market, characterized by its focus on innovation and commitment to providing high-performance ingredients. Croda International's strengths are highlighted by its extensive research capabilities, which allow the company to develop specialized omega-3 solutions tailored to specific market needs. The company has a reputation for producing premium quality products, underscored by rigorous testing and compliance with international standards, thereby fostering trust and reliability among its customers. Furthermore, Croda International's sustainable sourcing practices and dedication to environmental stewardship enhance its appeal in a market increasingly influenced by eco-conscious consumers.

With a well-established brand and a customer-centric approach, Croda International seeks to leverage its expertise in omega-3 ingredients to explore new opportunities and reinforce its position in the competitive landscape.

**Key Companies in the EPA and DHA Omega-3 Ingredient Market Include**

### Epa And Dha Omega-3 Ingredient Market Industry Developments

- **Q2 2024: GC Rieber VivoMega opens new omega-3 production facility in Norway** GC Rieber VivoMega inaugurated a new state-of-the-art omega-3 production facility in Kristiansund, Norway, expanding its capacity for high-concentration EPA and DHA ingredients to meet growing global demand.
- **Q1 2024: BASF launches new ultra-high purity EPA/DHA omega-3 ingredient for pharmaceuticals** BASF announced the launch of a new pharmaceutical-grade EPA/DHA omega-3 ingredient, designed for use in prescription products targeting cardiovascular and inflammatory conditions.
- **Q3 2024: DSM-Firmenich partners with Evonik to scale sustainable algal omega-3 production** DSM-Firmenich and Evonik entered a strategic partnership to expand the production of algal-based EPA and DHA omega-3 ingredients, aiming to supply both the nutraceutical and pharmaceutical sectors with sustainable alternatives to fish oil.
- **Q2 2024: Epax Norway AS appoints new CEO to drive global omega-3 expansion** Epax Norway AS announced the appointment of a new Chief Executive Officer, citing plans to accelerate international growth and innovation in high-concentration EPA/DHA omega-3 ingredients.
- **Q1 2024: Clover Corporation secures major supply contract for DHA omega-3 with leading infant formula manufacturer** Clover Corporation signed a multi-year supply agreement to provide DHA omega-3 ingredients to a top global infant formula producer, strengthening its position in the early life nutrition market.
- **Q3 2024: Solutex acquires microalgae facility to boost sustainable DHA production** Solutex completed the acquisition of a microalgae production facility in Spain, enhancing its capacity to produce high-purity, plant-based DHA omega-3 ingredients for food and supplement applications.
- **Q2 2024: BASF receives regulatory approval for new omega-3 pharmaceutical in Japan** BASF obtained regulatory clearance from Japanese authorities for its new prescription-grade EPA/DHA omega-3 product, enabling entry into the Japanese pharmaceutical market.
- **Q1 2024: Epax Norway AS launches next-generation high-potency EPA concentrate** Epax Norway AS introduced a new high-potency EPA concentrate ingredient, targeting the cardiovascular health and clinical nutrition markets with improved purity and bioavailability.
- **Q2 2024: GC Rieber VivoMega signs partnership with US supplement brand for exclusive omega-3 supply** GC Rieber VivoMega entered an exclusive supply agreement with a major US dietary supplement company to provide high-concentration EPA/DHA omega-3 oils for new product launches.
- **Q3 2024: DSM-Firmenich launches vegan omega-3 gummies with high DHA content** DSM-Firmenich released a new line of vegan omega-3 gummies featuring high DHA content sourced from microalgae, targeting the growing plant-based supplement market.
- **Q2 2024: Croda International opens new omega-3 innovation center in the UK** Croda International inaugurated a dedicated omega-3 innovation center in the United Kingdom, focusing on research and development of advanced EPA/DHA ingredients for functional foods and nutraceuticals.
- **Q1 2024: Clover Corporation receives regulatory approval for new DHA ingredient in China** Clover Corporation secured regulatory approval from Chinese authorities for its latest DHA omega-3 ingredient, enabling expanded sales into the Chinese infant formula and supplement markets.

**EPA and DHA Omega-3 Ingredient Market Segmentation Insights**

**EPA and DHA Omega-3 Ingredient Market Source Outlook**

Fish Oil  

Algal Oil  

Krill Oil  

Flaxseed Oil  

Chia Seed Oil  

**EPA and DHA Omega-3 Ingredient Market Form Outlook**

Liquid  

Softgel  

Powder  

Capsule  

Emulsion  

**EPA and DHA Omega-3 Ingredient Market Application Outlook**

Nutraceuticals  

Food  Beverages  

Pharmaceuticals  

Cosmetics  

Animal Feed  

**EPA and DHA Omega-3 Ingredient Market End-Use Outlook**

Human Health  

Pet Care  

Aquaculture  

Infant Formulas  

Functional Foods  

**EPA and DHA Omega-3 Ingredient Market Regional Outlook**

North America  

Europe  

South America  

Asia-Pacific  

Middle East and Africa  

## Market Drivers

### 对Omega-3益处的日益关注

EPA和DHA Omega-3成分的好处正越来越被广泛认可，这也促使它们在市场上的日益普及。研究表明，这些脂肪酸在减少炎症、改善心脏健康和增强大脑功能方面发挥着至关重要的作用。随着科学研究不断验证这些健康声明，消费者更倾向于将EPA和DHA Omega-3成分纳入他们的饮食中。EPA和DHA Omega-3成分市场正响应这一趋势，开发突出这些好处的创新产品，如富含Omega-3的食品和膳食补充剂。这种意识的提高不仅推动了销售，还鼓励制造商投资于教育消费者关于Omega-3消费优势的营销策略。因此，随着越来越多的人寻求通过纳入这些必需营养素来改善健康，市场可能会扩展。

### 欧米伽-3产品的监管支持

监管机构越来越认识到EPA和DHA Omega-3成分的重要性，导致支持性政策的出台，从而促进市场增长。各国政府正在推广Omega-3脂肪酸的消费，因其健康益处，这导致了对制造商的有利法规。这种支持在多个国家中显而易见，指导方针鼓励食品产品添加EPA和DHA Omega-3成分。EPA和DHA Omega-3成分市场受益于这种监管环境，因为它促进了创新，并鼓励公司开发满足消费者需求的新产品。此外，安全和质量标准的建立增强了消费者信任，进一步推动市场扩张。随着法规的不断演变，预计市场将见证投资和产品开发的增加，最终使寻求高质量Omega-3选择的消费者受益。

### 对营养补充剂需求的增加

对健康和保健意识的日益提高导致了对营养补充剂的需求不断增加，特别是那些含有EPA和DHA Omega-3成分的产品。消费者越来越主动关注自己的健康，寻求支持心血管健康、认知功能和整体福祉的产品。EPA和DHA Omega-3成分市场正在经历显著增长，预计到2026年市场规模将达到50亿美元。这一增长受到老龄化人口和慢性疾病普遍存在的推动，促使个人寻求预防健康措施。此外，这些成分的融入各种产品中，如功能性食品和饮料，正在扩大市场覆盖面，吸引更广泛的受众。随着消费者越来越重视健康，对EPA和DHA Omega-3成分的需求可能会继续上升。

### 欧米伽-3生产中的技术创新

EPA和DHA Omega-3成分的提取和生产技术进步正在改变市场格局。超临界CO2提取和酶处理等创新正在提高omega-3产品的效率和纯度。这些技术不仅提高了产量，还确保最终产品保持其营养完整性。EPA和DHA Omega-3成分市场正朝着更可持续的生产方法转变，这吸引了环保意识强的消费者。随着制造商采用这些尖端技术，他们更有能力满足对高质量omega-3成分日益增长的需求。这种对创新的关注可能会推动市场竞争，导致产品种类更加丰富，并可能降低消费者的价格。

### 植物性Omega-3来源的日益受欢迎

植物性饮食的趋势正在影响EPA和DHA Omega-3成分市场，因为消费者寻求替代的Omega-3脂肪酸来源。藻油作为EPA和DHA的植物性来源，正在受到素食者和严格素食者的青睐，他们在寻找可持续和伦理的选择。这一转变促使制造商探索创新的提取方法和产品配方，以满足这一人群的需求。植物性Omega-3成分的市场预计将显著增长，估计在未来几年复合年增长率将超过10%。随着越来越多的消费者采用植物性生活方式，来自藻类的EPA和DHA Omega-3成分的需求可能会增加，从而推动市场的多样化和扩展。

## Future Outlook

EPA和DHA Omega-3成分市场预计将在2024年至2035年间以5.33%的年复合增长率增长，推动因素是健康意识的提高和对功能性食品的需求。

**New opportunities:**

- 扩展植物基Omega-3配方

到2035年，市场预计将巩固其作为健康成分领导者的地位。

## Segment Insights

### 来源：鱼油（最大）与藻油（增长最快）

在EPA和DHA Omega-3成分市场中，按来源进行的细分显示出多样化的产品组合。鱼油仍然是最大的贡献者，因其在膳食补充剂和强化食品中的长期接受度而受到推动。另一方面，藻油因日益增长的素食主义和对植物基替代品的需求而获得关注。虾油、亚麻籽油和奇亚籽油的存在进一步丰富了市场，每种油都满足特定的消费者细分。这些来源共同为希望增加Omega-3摄入量的消费者提供了广泛的选择。

鱼油（主导）与藻油（新兴）

鱼油被认为是EPA和DHA Omega-3脂肪酸的主要来源，因为它得到了健康专业人士和公众的广泛认可。它通常来源于油性鱼类，富含这些对心血管健康至关重要的必需脂肪酸。另一方面，藻油作为市场上的强有力竞争者，特别吸引那些寻求植物基选择的人。藻油富含DHA，越来越受到素食者和环保消费者的欢迎。这个细分市场的兴起是由于对可持续性问题的日益关注，为进一步扩展创造了潜力。

### 按形式：液体（最大）与软胶囊（增长最快）

在EPA和DHA Omega-3成分市场中，细分市场的分布显著，液体形式占据了重要份额，成为最大的类别。另一方面，软胶囊在消费者中迅速获得关注，因其便利性和口感受到青睐。其他细分市场如粉末、胶囊和乳剂也为市场多样性做出贡献，但在市场份额上仍落后，液体和软胶囊占据领先地位。

液体（主导）与软胶囊（新兴）

液态EPA和DHA Omega-3成分因其多功能性和易于消费而主导市场，吸引了广泛的消费者群体，如注重健康的个人和运动员。它们的配方允许更高的生物利用度，确保有效吸收。相反，软胶囊格式正逐渐成为一种受欢迎的选择，特别是在那些寻求便利的膳食补充品的人群中。随着个性化营养趋势的增长，软胶囊提供了一种用户友好的选择，受到那些不喜欢油类味道的人的青睐。对软胶囊日益增长的偏好突显了消费者行为的变化，使其成为不断发展的Omega-3市场中的重要参与者。

### 按应用：营养保健品（最大）与药品（增长最快）

EPA和DHA Omega-3成分市场展示了多样的应用，其中营养保健品是最大的细分市场。随着消费者越来越多地将Omega-3补充剂纳入他们的健康和保健日常，意识到其众多好处，这一细分市场占据主导地位。制药行业也正在成为一个重要的细分市场，得益于基于Omega-3的心脏健康和心理健康药物的不断开发，使其成为该市场增长最快的领域之一。

营养保健品：主流与药品：新兴

营养保健品在EPA和DHA Omega-3成分市场中占据主导地位，提供多种补充剂以满足健康意识强的消费者。该细分市场的产品种类繁多，从胶囊到液体形式，受益于消费者向预防性医疗的强劲转变。另一方面，制药行业虽然处于新兴阶段，但利用了大量的科学研究，推动了在特定健康问题治疗中Omega-3应用的创新。Omega-3在慢性疾病如心脏病中的处方增长突显了它们在医疗行业的预期影响，最终推动了该细分市场的需求。

### 按最终用途：人类健康（最大）与水产养殖（增长最快）

在EPA和DHA Omega-3成分市场中，最终使用细分市场的市场份额分布显示人类健康是最大的细分市场，这得益于消费者对Omega-3脂肪酸对心血管健康和整体健康益处的日益关注。紧随其后，宠物护理细分市场对市场动态也有显著贡献，而水产养殖细分市场随着可持续渔业养殖实践的兴起正在迅速获得关注。同时，婴儿配方奶粉和功能性食品在市场生态系统中也发挥着关键作用，满足特定的健康需求和饮食偏好。

人类健康：主流与水产养殖：新兴

人类健康领域在EPA和DHA Omega-3成分市场中脱颖而出，成为主导力量，利用健康意识生活和预防医疗措施的上升趋势。消费者越来越重视富含Omega-3的饮食，寻求补充剂和强化食品以改善健康结果。相比之下，水产养殖领域正在崛起，受益于对可持续海鲜和环保养殖实践的需求。水产养殖方法的创新以及对可追溯性和质量的日益重视，使得Omega-3成分成为鱼饲料配方中不可或缺的一部分，符合消费者的兴趣和可持续发展目标。

## Regional Market Share Analysis

EPA和DHA Omega-3成分市场预计将在各个区域细分中经历显著增长。2023年，北美以9.3亿美元的市场估值占据主导地位，预计到2032年将上升至14.04亿美元，显示出其在市场中的主要份额。欧洲紧随其后，从7.75亿美元增至12.48亿美元，表明消费者对健康益处的认识推动了其显著需求。同时，亚太地区预计将从8.53亿美元增长至14.82亿美元，随着健康意识的提高和可支配收入的增加，市场消费也在提升。

南美在2023年的估值为5.43亿美元，预计也将稳步增长至7.8亿美元，反映出膳食补充剂采用的增加。中东和非洲地区虽然在2023年的估值最低，仅为3.49亿美元，但预计将增长至5.85亿美元，表明对Omega-3补充剂的逐渐兴趣。这些地区的价值分布突显了意识、监管支持和消费者趋势的不同水平，促进了整体EPA和DHA Omega-3成分市场的收入。

来源：初级研究，次级研究，_市场研究未来_数据库和分析师评审

## Competitive Benchmarking

EPA和DHA Omega-3成分市场近年来获得了显著的关注，这得益于人们对Omega-3脂肪酸相关健康益处的认识不断提高。该市场的竞争格局由一系列成熟企业和新兴公司组成，这些公司通过各种策略努力巩固自己的地位。这些策略包括技术进步、产品多样化以及在研究和开发方面的合作，以满足不断变化的消费者需求。

向更健康饮食选择的推动促使公司进行创新和扩展其产品组合，旨在满足健康意识消费者的需求，并利用Omega-3脂肪酸在膳食补充剂、食品和饮料以及制药等多种应用中的潜力。竞争环境以激烈的竞争、监管挑战以及对可持续原材料采购的需求为特征，进一步复杂地塑造了市场动态和增长路径。

Cargill在EPA和DHA Omega-3成分市场中建立了显著的市场存在，利用其在食品和营养领域的丰富经验和资源。Cargill的优势在于其卓越的制造能力、全面的供应链整合以及对可持续性的承诺，这与日益增长的消费者对道德采购成分的需求相契合。该公司的强大研发努力使其能够创新并生产符合严格监管标准的高质量Omega-3产品，以满足多样化的饮食需求。

此外，Cargill的市场足迹使其能够有效地与广泛的客户群体互动，与食品和饮料、膳食补充剂以及宠物营养等各个行业的客户建立牢固的关系。这一战略定位支撑了Cargill在市场中保持竞争优势的能力，并能够灵活应对新兴趋势。

Croda International是EPA和DHA Omega-3成分市场的另一个关键参与者，其特点是专注于创新和提供高性能成分的承诺。Croda International的优势体现在其广泛的研究能力上，使公司能够开发针对特定市场需求的专业Omega-3解决方案。该公司以生产优质产品而闻名，经过严格测试并符合国际标准，从而在客户中建立了信任和可靠性。此外，Croda International的可持续采购实践和对环境保护的承诺增强了其在日益受到生态意识消费者影响的市场中的吸引力。

凭借成熟的品牌和以客户为中心的方法，Croda International寻求利用其在Omega-3成分方面的专业知识，探索新机会并巩固其在竞争格局中的地位。

## Recent News & Developments

- **2024年第二季度：GC Rieber VivoMega在挪威开设新的omega-3生产设施** GC Rieber VivoMega在挪威克里斯蒂安松揭幕了一座最先进的omega-3生产设施，扩大了其高浓度EPA和DHA成分的产能，以满足日益增长的全球需求。
- **2024年第一季度：巴斯夫推出新的超高纯度EPA/DHA omega-3药用成分** 巴斯夫宣布推出一种新的药用级EPA/DHA omega-3成分，旨在用于针对心血管和炎症疾病的处方产品。
- **2024年第三季度：DSM-Firmenich与Evonik合作扩大可持续藻类omega-3生产** DSM-Firmenich与Evonik达成战略合作伙伴关系，扩大藻类EPA和DHA omega-3成分的生产，旨在为营养保健和制药行业提供可持续的鱼油替代品。
- **2024年第二季度：Epax Norway AS任命新首席执行官以推动全球omega-3扩展** Epax Norway AS宣布任命新首席执行官，表示计划加速国际增长和高浓度EPA/DHA omega-3成分的创新。
- **2024年第一季度：Clover Corporation与领先的婴儿配方奶粉制造商签署DHA omega-3重大供应合同** Clover Corporation签署了一项多年供应协议，为一家全球顶级婴儿配方奶粉生产商提供DHA omega-3成分，巩固其在早期生命营养市场的地位。
- **2024年第三季度：Solutex收购微藻设施以提升可持续DHA生产** Solutex完成了对西班牙一家微藻生产设施的收购，增强了其生产高纯度植物基DHA omega-3成分的能力，适用于食品和补充剂应用。
- **2024年第二季度：巴斯夫获得日本新omega-3药物的监管批准** 巴斯夫获得日本当局对其新处方级EPA/DHA omega-3产品的监管批准，进入日本药品市场。
- **2024年第一季度：Epax Norway AS推出下一代高效EPA浓缩物** Epax Norway AS推出了一种新的高效EPA浓缩物，针对心血管健康和临床营养市场，具有更高的纯度和生物利用度。
- **2024年第二季度：GC Rieber VivoMega与美国补充剂品牌签署独家omega-3供应协议** GC Rieber VivoMega与一家主要的美国膳食补充剂公司签署了独家供应协议，为新产品发布提供高浓度EPA/DHA omega-3油。
- **2024年第三季度：DSM-Firmenich推出高DHA含量的素食omega-3软糖** DSM-Firmenich推出了一系列高DHA含量的素食omega-3软糖，原料来自微藻，目标是日益增长的植物基补充剂市场。
- **2024年第二季度：Croda International在英国开设新的omega-3创新中心** Croda International在英国揭幕了一座专门的omega-3创新中心，专注于功能性食品和营养保健品的先进EPA/DHA成分的研发。
- **2024年第一季度：Clover Corporation获得中国新DHA成分的监管批准** Clover Corporation获得中国当局对其最新DHA omega-3成分的监管批准，扩大在中国婴儿配方奶粉和补充剂市场的销售。

## Report Scope

| 2024年市场规模 | 3.821（十亿美元） |
| --- | --- |
| 2025年市场规模 | 4.025（十亿美元） |
| 2035年市场规模 | 6.767（十亿美元） |
| 复合年增长率（CAGR） | 5.33%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 对植物基EPA和DHA Omega-3成分的消费者需求增长带来了显著的市场机会。 |
| 主要市场动态 | 对可持续来源的消费者需求上升推动了EPA和DHA Omega-3成分市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，EPA和DHA Omega-3成分市场的预计市场估值是多少？**
A: 预计到2035年，EPA和DHA Omega-3成分市场的市场估值为67.67亿美元。

**Q: 2024年EPA和DHA Omega-3成分市场的市场估值是多少？**
A: 2024年EPA和DHA Omega-3成分市场的市场估值为38.21亿美元。

**Q: 2025年至2035年期间EPA和DHA Omega-3成分市场的预期CAGR是多少？**
A: 预计2025年至2035年期间EPA和DHA Omega-3成分市场的年均增长率（CAGR）为5.33%。

**Q: 在EPA和DHA Omega-3成分市场中，哪些公司被视为关键参与者？**
A: 市场上的主要参与者包括DSM营养产品、巴斯夫公司、嘉吉公司和欧米伽蛋白公司。

**Q: 市场上EPA和DHA Omega-3成分的主要来源是什么？**
A: 主要来源包括鱼油、藻油、磷虾油、亚麻籽油和奇亚籽油，其中鱼油在2035年的价值为45亿美元。

**Q: 市场上有哪些形式的EPA和DHA Omega-3成分可供选择？**
A: 可用形式包括液体、软胶囊、粉末、胶囊和乳剂，预计到2035年软胶囊将达到22亿美元。

**Q: EPA和DHA Omega-3成分主要用于哪些应用？**
A: EPA和DHA Omega-3成分主要用于营养保健品、食品和饮料、制药、化妆品以及动物饲料。

**Q: 到2035年，营养保健品应用领域的预计估值是多少？**
A: 预计到2035年，营养保健品应用领域的估值为27亿美元。

**Q: 哪些最终使用领域正在推动EPA和DHA Omega-3成分的需求？**
A: 需求受到人类健康、宠物护理、水产养殖、婴儿配方奶粉和功能性食品的推动。

**Q: 到2035年，水产养殖最终用途细分市场的预期市场估值是多少？**
A: 预计到2035年，水产养殖终端使用细分市场的市场估值为16亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/epa-and-dha-omega-3-ingredient-market-38303*